Breaking News, Collaborations & Alliances

Shanghai Institute, Crown Bioscience Enter Strategic Pact

To develop mouse clinical center and translational oncology platform

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences (CAS), and Crown Bioscience, Inc., have formed a strategic collaboration focused on translational oncology and will join forces to build a mouse clinical trial center called SIMM-Crown Mouse Clinical Trial Center (SCMC), at Crown Taicang campus, in Taicang, Jiangsu province, China. The partnership aims to build the world’s first and largest mouse clinical center featuring advanced translational oncology platforms with full...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters